Dr. George Ansstas, M.D.
Claim this profileWashington University School of Medicine
Studies Skin Cancer
Studies Glioblastoma
19 reported clinical trials
36 drugs studied
About George Ansstas, M.D.
Education:
- Earned an MD (Doctor of Medicine) from Washington University School of Medicine.
Experience:
- Currently serves as a medical and neuro-oncologist at Siteman Cancer Center, Washington University School of Medicine, with a focus on brain tumors, skin cancer, and melanoma.
Area of expertise
1Skin Cancer
Stage IV
Stage III
Stage I
2Glioblastoma
germline
tumor
MGMT
Affiliated Hospitals
Clinical Trials George Ansstas, M.D. is currently running
Pembrolizumab + Radiation Therapy
for Melanoma
This is an open-label, single center, one cohort, non-randomized, phase II study. The aim is to evaluate the efficacy and safety of the combination of hypofractionated radiotherapy (HRT) and pembrolizumab on local tumor control in mucosal melanoma patients. Treatment effect will be compared with historical radiation therapy-alone control data.
Recruiting1 award Phase 212 criteria
Immunotherapy + Prednisone + Sirolimus
for Skin Cancer
This phase II trial tests the combination of nivolumab and ipilimumab with sirolimus and prednisone for the treatment of skin (cutaneous) cancer that cannot be removed by surgery (unresectable) or that has spread from where it first started to other places in the body (metastatic) in kidney transplant recipients. Immunotherapy with nivolumab and ipilimumab, may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Sirolimus and prednisone are immunosuppressants that are given to keep the body from rejecting the transplanted kidney. Giving nivolumab and ipilimumab in combination with sirolimus and prednisone may kill more cancer cells, while also keeping the transplanted kidney healthy, in patients with unresectable or metastatic cutaneous cancer who have received a kidney transplant.
Recruiting1 award Phase 1 & 210 criteria
More about George Ansstas, M.D.
Clinical Trial Related7 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments George Ansstas, M.D. has experience with
- Nivolumab
- Pembrolizumab
- Ipilimumab
- Personalized Neoantigen DNA Vaccine
- Avelumab
- Surgery
Breakdown of trials George Ansstas, M.D. has run
Skin Cancer
Glioblastoma
Melanoma
Brain Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does George Ansstas, M.D. specialize in?
George Ansstas, M.D. focuses on Skin Cancer and Glioblastoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is George Ansstas, M.D. currently recruiting for clinical trials?
Yes, George Ansstas, M.D. is currently recruiting for 5 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that George Ansstas, M.D. has studied deeply?
Yes, George Ansstas, M.D. has studied treatments such as Nivolumab, Pembrolizumab, Ipilimumab.
What is the best way to schedule an appointment with George Ansstas, M.D.?
Apply for one of the trials that George Ansstas, M.D. is conducting.
What is the office address of George Ansstas, M.D.?
The office of George Ansstas, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.